FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc. under ANDA 078085, finalizing changes to the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension
• Myocardial Infarction
• Tachyarrhythmia

Drugs mentioned

• METOPROLOL TARTRATE (METOPROLOL TARTRATE)

Snippet

SUPPL AP for METOPROLOL TARTRATE (METOPROLOL TARTRATE)